Document Classification

Section Type: RESULTS

Text: At endpoint, FP was more effective than montelukast at decreasing rescue albuterol use (3. 1 puffs/day vs 2. 3 puffs/day, P <. 001), asthma symptom scores (-0. 85 [48. 6 % decrease] vs -0. 60 [30. 5 %], P <. 001), and nighttime awakenings due to asthma (-0. 64 awakenings/night [62 % decrease] vs -0. 48 awakenings/night [47. 5 %], P =. 023), and FP increased the percentage of symptom-free days (32. 0 % vs 18. 4 % of days, P <. 001) compared with montelukast.